Marvin & Palmer Associates Inc Edwards Lifesciences Corp Transaction History

Marvin & Palmer Associates Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$101.96 - $128.34 $9.37 Million - $11.8 Million	-91,933 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $1.11 Million - $1.37 Million	-10,449 Reduced 10.21%	91,933 $11.9 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $10.5 Million - $12.6 Million	102,382 New	102,382 $11.6 Million
Q1 2021 Jun 24, 2021	SELL	$78.68 - $90.67 $7.91 Million - $9.12 Million	-100,588 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $284,896 - $362,548	3,974 Added 4.11%	100,588 $8.31 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $658,663 - $857,174	9,803 Added 11.29%	96,614 $7.71 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $3.57 Million - $4.77 Million	61,991 Added 249.76%	86,811 $6 Million
Q1 2020 May 12, 2020	SELL	$52.41 - $81.0 $249,576 - $385,722	-4,762 Reduced 16.1%	24,820 $4.68 Million
Q4 2019 Feb 11, 2020	BUY	$71.7 - $82.09 $2.12 Million - $2.43 Million	29,582 New	29,582 $6.9 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Marvin & Palmer Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Marvin & Palmer Associates Inc with notifications on news.